Showing results (281-290 of 292) with videos related to
Sort By:
Pageof 30
Applied Health Economics and Health Policy|November 8, 2019
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of OlaratumabCaridad Pontes, Corinne Zara, Josep Torrent-Farnell, et al.Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.Frontiers in Pharmacology|February 7, 2018
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian CountriesTomasz Bochenek, Vafa Abilova, Ali Alkan, et al.Pharmacoeconomics|August 1, 2020
Integrative Review of Managed Entry Agreements: Chances and LimitationsCarolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, et al.BMC Medicine|August 15, 2013
Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.Frontiers in Pharmacology|May 30, 2013
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.Pageof 30